BloodSTOP® is a natural, biocompatible, non-irritating, animal-free material that adheres to a wound, absorbs blood, stops bleeding, and forms a protective layer to create an environment for wound healing. Its water solubility allows it to be rinsed off without disruption to the clotted surface.
News Releases
12/06/12
BloodSTOP now approved in EU for use with blood thinning medications!
LifeSciencePLUS, Inc., is pleased to announce the recertification of its Class IIb CE Mark Certification for the BloodSTOP® line of topical hemostats. The recertification has been extended to include bleeding control for people on anti-coagulant medications.
09/28/12
Efficacy Studies of BloodSTOP® iX as compared with Surgicel® and Gelfoam®
UCSF preclinical study done in conjunction with University Hospital Pellegrin in France shows BloodSTOP iX® controls bleeding up to three times faster than Gelfoam® or Surgicel®.
05/01/12
BloodSTOP® and BloodSTOP® iX Effective at Controlling Bleeding on Test Subjects Receiving Coumadin, Aspirin & Plavix, and Heparin
A preclinical study performed in accordance with GLP guidelines, tested BloodSTOP and BloodSTOP iX on a group of animals receiving anticoagulant drugs against a control subject that received none. Tests showed hemostasis was achieved in the anticoagulant group in a time that was statistically significant and comparable to that of the control subject.
04/10/12
Walgreens and Curad brands now offer our hemostat technology
LifeScience PLUS, Inc., announces today that it has partnered with Medline Industries for the launch of Curad® BloodSTOP and Walgreens® Blood Barrier Hemostat Gauze with its BloodSTOP technology.
03/08/12
BloodSTOP on ABC7 News, KGO-TV, San Francisco!
Watch the news story which covered BloodSTOP products from ABC7 News, KGO-TV, San Francisco.
03/01/11
BloodSTOP® Technology Picked up by CVS Drug Stores
LifeScience PLUS, Inc., announces today that it has signed a store brand agreement for the supply of its proprietary hemostat technology to CVS.
04/17/10
LifeScience PLUS Sends BloodSTOP® Products to Haiti
LifeScience PLUS has donated $43,000 worth of BloodSTOP products to the Haiti earthquake relief effort through theCatholic Medical Mission Board for the medical treatment of wounds sustained in the recent crisis.
11/25/09
KERR DRUG Offers Customers the Exciting New Hemostat, BloodSTOP
Kerr Drug has brought a new bleeding control solution to their market with the introduction of BloodSTOP®Hemostatic Gauze, manufactured by LifeScience PLUS.
01/22/09
LifeSciencePLUS Obtains the CE Mark for BloodSTOP® iX Absorbable Hemostat
LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® iX Absorbable Hemostat has been granted the Class III CE Mark certification for internal wounds. Already in medical markets overseas as a surface wound hemostat, BloodSTOP® iX will now be offered to the internal, surgical market in Europe.
10/15/08
LifeScience PLUS Introduces BloodSTOP
LifeScience PLUS today announced the introduction of its proven fast-acting BloodSTOP hemostatic products in global markets. The company's patent pending hemostatic technology brings a new level of efficacy to the wound care market.
11/01/07
LifeSciencePLUS Obtains CE Mark Certification for the BloodSTOP® Product Line
LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® has been granted the Class IIb CE Mark certification for the control of bleeding from all surface wounds. “We are pleased to be able to extend our markets for this breakthrough product beyond the US and into the European markets,” said Vicky Feng, President and CEO.
09/01/07
FDA Clearance of BloodSTOP® Leads to New Retail Wound Management Category
BloodSTOP®, a 100% natural fiber cellulose gauze which quickly stops bleeding, has now been cleared by FDA for marketing to consumers. BloodSTOP®, initially used by Medical Professionals to effectively manage blood loss and speed up healing, has now been designed for the consumer and is available at drug stores.
02/01/06
BloodSTOP featured in "Dentistry Today"
Dr. George Fredman, DDS, gives his impressions of BloodSTOP® based on his clinical experience.
